Expert Opinion on Drug Discovery (EODD)
Journal Descriptions
Expert Opinion on Drug Discovery (1746-0441; 1746-045X) is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles in drug discovery. Expert Opinion on Drug Discovery publishes original research and review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimization at the preclinical level. Articles focus on the following key areas: Chemoinformatics Bioinformatics Assay development Novel screening technologies In vitro/in vivo models Structure-based drug design Systems biology
Expert Opinion on Drug Discovery (EODD) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Chemoinformatics, Bioinformatics, Assay development, Novel screening technologies, In vitro/in vivo models, Systems biology, Structure-based drug design , Online or Print , Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1746-0441, E-ISSN: 1746-045X, Established: 2006, Impact Factor: 6.0
- Provides Crossref DOI
-
Indexed in: Scopus, WoS
-
Not indexed in DOAJ, PubMed, UGC CARE
